DEMETROUS JOHNSTON: Open Payments
NPI 1407460413 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 34 payments from 5 companies in 2025. Trend: 2023 $1,242 · 2024 $1,646 · 2025 $1,023
Food & beverage: $1,013Education: $10
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 24 | $689 |
| ABBVIE INC. | 5 | $142 |
| E.R. Squibb & Sons, L.L.C. | 1 | $105 |
| Alkermes, Inc. | 3 | $72 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: UZEDY, VRAYLAR, COBENFY, ARISTADA, Qelbree.
Industry payments across VA — which companies pay providers there.
